Preclinical ex vivo IL2RG gene therapy using autologous hematopoietic stem cells as an effective and safe treatment for X-linked severe combined immunodeficiency disease
Mingzhi Hu(China International Science and Technology Cooperation), Yunfei An(Sichuan University)
Cited by 6
Related Papers
UBE2D1 as a key biomarker in systemic juvenile idiopathic arthritis: a new perspective on diagnosis and disease activity assessment
|Arthritis Research & Therapy|2025|4
Case report: A cyclic neutropenia patient with ELANE mutation accompanied by hemophagocytic lymphohistiocytosis
|Frontiers in Immunology|2024|2
Efficacy of upadacitinib in treating a paediatric case of refractory Takayasu arteritis
|Lara D. Veeken|2025|2